Nothing Special   »   [go: up one dir, main page]

DE69719539D1 - Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten - Google Patents

Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten

Info

Publication number
DE69719539D1
DE69719539D1 DE69719539T DE69719539T DE69719539D1 DE 69719539 D1 DE69719539 D1 DE 69719539D1 DE 69719539 T DE69719539 T DE 69719539T DE 69719539 T DE69719539 T DE 69719539T DE 69719539 D1 DE69719539 D1 DE 69719539D1
Authority
DE
Germany
Prior art keywords
activity
natural killer
increase
killer lymphocytes
linolic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69719539T
Other languages
English (en)
Inventor
E Cook
Sohee Kim
W Pariza
Danielle Devoney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of DE69719539D1 publication Critical patent/DE69719539D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
DE69719539T 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten Expired - Lifetime DE69719539D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3039496P 1996-11-05 1996-11-05
PCT/US1997/020098 WO1998019675A1 (en) 1996-11-05 1997-11-04 Use of conjugated linoleic acid to enhance natural killer lymphocyte function

Publications (1)

Publication Number Publication Date
DE69719539D1 true DE69719539D1 (de) 2003-04-10

Family

ID=21854010

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719539T Expired - Lifetime DE69719539D1 (de) 1996-11-05 1997-11-04 Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten

Country Status (8)

Country Link
US (1) US5914346A (de)
EP (1) EP0941088B1 (de)
JP (1) JP2001503430A (de)
AT (1) ATE233557T1 (de)
AU (1) AU5104198A (de)
CA (1) CA2267109C (de)
DE (1) DE69719539D1 (de)
WO (1) WO1998019675A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776353B1 (en) * 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1231913A2 (de) * 1999-07-09 2002-08-21 Pharmacia Corporation Behandlung von cyclooxygenase-2 bedingten erkrankungen unter verwendung von conjugierten fettsäureverbindungen
US6077868A (en) * 1999-07-20 2000-06-20 Wisconsin Alumni Research Foundation Selective inhibition of cyclooxygenase-2
WO2001077271A2 (en) * 2000-04-06 2001-10-18 Conlinco, Inc. Conjugated linoleic acid compositions
JP4786030B2 (ja) * 2000-12-27 2011-10-05 森永乳業株式会社 ナチュラルキラー細胞活性化剤
US6395782B1 (en) 2001-03-02 2002-05-28 Wisconsin Alumni Research Foundation Method of increasing longevity and preventing body weight wasting in autoimmune disease by using conjugated linoleic acid
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2005063230A1 (en) * 2003-12-30 2005-07-14 Universite Laval Use of conjugated linolenic acids for reducing body fat mass
JP2005194222A (ja) * 2004-01-06 2005-07-21 Otsuka Pharmaceut Factory Inc サイトカイン誘発剤
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
EP1765964A4 (de) * 2004-04-30 2007-11-07 Synthese von salzen aus mehrfach ungesättigten fettsäuren und ein- und zweiwertigen metallen
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US20070116675A1 (en) 2004-09-15 2007-05-24 Tetsuya Kuhara Drug and method for proliferating natural killer cells
KR100843508B1 (ko) 2004-09-29 2008-07-04 모리나가 뉴교 가부시키가이샤 고혈당 개선용 의약
DK1835021T3 (da) 2004-12-28 2011-04-18 Meiji Seika Kaisha Ny stamme tildelt anti-sygdomsegenskaber mod værts- og bakteriel cellesammensætning

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282265A (en) * 1980-01-14 1981-08-04 Bristol-Myers Company Fat compositions for infant formulas
IE54795B1 (en) * 1982-04-29 1990-02-14 Efamol Ltd Pharmaceutical composition
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
JPS61216658A (ja) * 1985-03-20 1986-09-26 Agency Of Ind Science & Technol 生理活性物質を含有する卵、肉、および乳
JPS6398355A (ja) * 1986-10-16 1988-04-28 Kazumitsu Maruta 動物用飼料
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5045338A (en) * 1989-09-19 1991-09-03 Nabisco Brands, Inc. Secondary amide esters as low calorie fat mimetics
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
WO1992010105A1 (en) * 1990-12-07 1992-06-25 Nabisco, Inc. Reduced calorie triglyceride mixtures
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5428072A (en) * 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
US5554646A (en) * 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
JP3138358B2 (ja) * 1993-03-31 2001-02-26 雪印乳業株式会社 共役リノール酸の製造方法およびそれを含有させた食品
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5760082C1 (en) * 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
US5814663A (en) * 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
DE69615513T2 (de) * 1995-11-14 2002-05-08 Unilever N.V., Rotterdam Essbarer Brotaufstrich

Also Published As

Publication number Publication date
WO1998019675A1 (en) 1998-05-14
JP2001503430A (ja) 2001-03-13
CA2267109A1 (en) 1998-05-14
CA2267109C (en) 2006-08-22
EP0941088A1 (de) 1999-09-15
AU5104198A (en) 1998-05-29
ATE233557T1 (de) 2003-03-15
US5914346A (en) 1999-06-22
EP0941088B1 (de) 2003-03-05

Similar Documents

Publication Publication Date Title
DE69719539D1 (de) Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
DE69513998D1 (de) Verwendung von 2'-substituierten oligonukleotiden zur reduzierung der genexpression
DK0731699T3 (da) Fremgangsmåde til reduktion af legemsfedt i dyr ved indgivelse af konjugeret linolsyre
ATE83263T1 (de) Regulatorregion fuer die expression von heterologen genen in hefe.
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
AU3139097A (en) Methods of preventing skeletal problems in poultry
ATE213390T1 (de) Wirkstoff zur erhöhung der produktion und der zucht von tieren in der geflügelindustrie
DK486587A (da) Gen, kodende for humane kolonistimulerende faktorer
DE3689055D1 (de) Vorrichtung zur Erzeugung höherer Oberwellen.
ATE180409T1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
DE3873945D1 (de) Verwendung von polyglutaminsaeure in nahrungsmitteln.
DE69840637D1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE69621146D1 (de) Verwendung von Galactanase in Tierfutter
DE59606907D1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
MX230817B (en) Method of increasing fat firmness and improving meat quality in animals
DE3877008D1 (de) Geraet zur sukzessiven umwandlung von zeitperioden in spannung.
IT8120772A0 (it) Procedimento per modificare i prodotti in fibra animale strappando le scaglie.
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
DE3787653D1 (de) Biotechnischer monitor zur kontinuierlichen bestimmung von schadwirkungen auf mikroorganismen in wasser.
DE68910685D1 (de) Verfahren zur Konvertierung von Erdgas in Mitteldestillate.
ATE275414T1 (de) Verfahren zur behandlung endzünlicher darmerkrankungen durch verwendung von choleratoxin untereinheit b
DE60028750D1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
ATE182744T1 (de) Vorrichtung zum elektrischen betäuben von schlachttieren

Legal Events

Date Code Title Description
8332 No legal effect for de